Chemoinformaics analysis of 2-Cyclohexylidenecyclohexanone
| Molecular Weight | 178.275 | nRot | 0 |
| Heavy Atom Molecular Weight | 160.131 | nRig | 14 |
| Exact Molecular Weight | 178.136 | nRing | 2 |
| Solubility: LogS | -3.834 | nHRing | 0 |
| Solubility: LogP | 3.597 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 32.8443 |
| nHD | 0 | BPOL | 18.9257 |
| QED | 0.52 |
| Synth | 2.461 |
| Natural Product Likeliness | 0.606 |
| NR-PPAR-gamma | 0.391 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.933 |
| Pgp-sub | 0.001 |
| HIA | 0.006 |
| CACO-2 | -4.715 |
| MDCK | 0.0000214 |
| BBB | 0.646 |
| PPB | 0.920425 |
| VDSS | 0.887 |
| FU | 0.0271197 |
| CYP1A2-inh | 0.922 |
| CYP1A2-sub | 0.858 |
| CYP2c19-inh | 0.649 |
| CYP2c19-sub | 0.083 |
| CYP2c9-inh | 0.519 |
| CYP2c9-sub | 0.52 |
| CYP2d6-inh | 0.724 |
| CYP2d6-sub | 0.186 |
| CYP3a4-inh | 0.136 |
| CYP3a4-sub | 0.241 |
| CL | 2.888 |
| T12 | 0.539 |
| hERG | 0.016 |
| Ames | 0.02 |
| ROA | 0.07 |
| SkinSen | 0.897 |
| Carcinogencity | 0.59 |
| EI | 0.804 |
| Respiratory | 0.663 |
| NR-Aromatase | 0.122 |
| Antiviral | No |
| Prediction | 0.659208 |